sabinene has been researched along with Atherogenesis in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (63.64) | 24.3611 |
2020's | 4 (36.36) | 2.80 |
Authors | Studies |
---|---|
Chen, XL; Gong, MJ; Huang, ZH; Liang, PL; Liao, BS; Qiu, XH; Tu, HS; Xu, W; Xu, Y; Zhang, J; Zhang, L | 1 |
Jiang, JG; Lin, JJ; Shen, CY; Wang, TX; Zhu, W | 1 |
Caimari, A; Crescenti, A; Del Bas, JM; Domenech-Coca, C; Escoté, X; Mas-Capdevila, A; Teichenne, J | 1 |
Castro, MA; Crespo, R; Galle, ME; Gavernet, L; Llanos, MA; Rodenak-Kladniew, BE | 1 |
Burke, AC; Drangova, M; Edwards, JY; Huff, MW; Morrow, MR; Sawyez, CG; Sutherland, BG; Telford, DE | 1 |
Chen, PY; Ho, CT; Koh, YC; Li, S; Pan, MH; Wu, JC; Yang, MJ | 1 |
Brighenti, F; Calani, L; Curella, V; Dall'Asta, M; Del Rio, D; Derlindati, E; Mena, P; Ray, S; Zavaroni, I | 1 |
Cappello, AR; Curcio, R; Dhanyalayam, D; Dolce, V; Fiorillo, M; Iacopetta, D; Martello, M; Muto, L | 1 |
Burke, AC; Huff, MW; Mulvihill, EE | 1 |
Fu, SH; Ho, CT; Li, S; Lo, YH; Pan, MH; Weng, CY; Wu, MJ; Yen, JH | 1 |
Assini, JM; Huff, MW; Mulvihill, EE | 1 |
4 review(s) available for sabinene and Atherogenesis
Article | Year |
---|---|
Effect of Hesperidin on Cardiovascular Disease Risk Factors: The Role of Intestinal Microbiota on Hesperidin Bioavailability.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Biological Availability; Cardiovascular Diseases; Cardiovascular System; Citrus; Dysbiosis; Dyslipidemias; Flavanones; Gastrointestinal Microbiome; Hesperidin; Humans; Obesity; Risk Factors | 2020 |
Bergamot (Citrus bergamia Risso) Flavonoids and Their Potential Benefits in Human Hyperlipidemia and Atherosclerosis: an Overview.
Topics: Animals; Atherosclerosis; Citrus; Flavonoids; Humans; Hyperlipidemias; Molecular Structure | 2016 |
Citrus Flavonoids as Regulators of Lipoprotein Metabolism and Atherosclerosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Obesity Agents; Antioxidants; Atherosclerosis; Citrus; Diabetes Mellitus, Type 2; Dietary Supplements; Flavonoids; Humans; Hyperlipidemias; Hypolipidemic Agents; Insulin Resistance; Lipoproteins; Non-alcoholic Fatty Liver Disease; Overweight; Risk Factors | 2016 |
Citrus flavonoids and lipid metabolism.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Citrus; Dyslipidemias; Flavanones; Flavones; Hesperidin; Humans; Hypolipidemic Agents; Inflammation; Lipid Metabolism; Oxidation-Reduction; Phytotherapy | 2013 |
7 other study(ies) available for sabinene and Atherogenesis
Article | Year |
---|---|
Guang Chen Pi (the pericarp of Citrus reticulata Blanco's cultivars 'Chachi') inhibits macrophage-derived foam cell formation.
Topics: Atherosclerosis; Cholesterol; Citrus; Foam Cells; Lipoproteins, LDL; Macrophages; PPAR gamma | 2022 |
Potential roles of dietary flavonoids from Citrus aurantium L. var. amara Engl. in atherosclerosis development.
Topics: Animals; Atherosclerosis; Citrus; Disease Progression; Flavonoids; Humans; Interleukin-1beta; Interleukin-6; Macrophages; Mice; NF-kappa B; Plant Extracts; RAW 264.7 Cells; Tumor Necrosis Factor-alpha | 2020 |
Citrus reticulata peel oil as an antiatherogenic agent: Hypolipogenic effect in hepatic cells, lipid storage decrease in foam cells, and prevention of LDL oxidation.
Topics: Animals; Antioxidants; Atherosclerosis; CD36 Antigens; Cholesterol; Citrus; Dyslipidemias; Foam Cells; Fruit; Hep G2 Cells; Hepatocytes; Humans; Hypolipidemic Agents; Intramolecular Transferases; Lipid Peroxidation; Lipoproteins, LDL; Mice; Molecular Docking Simulation; Plant Oils; RAW 264.7 Cells | 2020 |
Intervention with citrus flavonoids reverses obesity and improves metabolic syndrome and atherosclerosis in obese
Topics: Adipose Tissue; Animals; Atherosclerosis; Body Weight; Cholesterol; Citrus; Diet, High-Fat; Energy Metabolism; Flavonoids; Hyperlipidemias; Insulin Resistance; Macrophages; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Monocytes; Obesity; Receptors, LDL | 2018 |
Oolong Tea Extract and Citrus Peel Polymethoxyflavones Reduce Transformation of l-Carnitine to Trimethylamine-
Topics: Animals; Atherosclerosis; Bacteria; Biotransformation; Camellia sinensis; Carnitine; Citrus; Female; Flavones; Gastrointestinal Microbiome; Gastrointestinal Tract; Humans; Methylamines; Mice; Mice, Inbred C57BL; Plant Extracts; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2019 |
Effects of naringenin and its phase II metabolites on in vitro human macrophage gene expression.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Cell Culture Techniques; Citrus; Diet; Flavanones; Gene Expression; Humans; Macrophages; Metabolic Detoxication, Phase II; Plant Extracts | 2013 |
Citrus flavonoid 5-demethylnobiletin suppresses scavenger receptor expression in THP-1 cells and alters lipid homeostasis in HepG2 liver cells.
Topics: Atherosclerosis; CD11b Antigen; Cell Differentiation; Citrus; Flavones; Foam Cells; Hep G2 Cells; Humans; Hydroxymethylglutaryl CoA Reductases; Lipid Metabolism; Macrophages; Monocytes; NF-kappa B; Protein Kinase C; Receptors, LDL; Receptors, Scavenger; Tetradecanoylphorbol Acetate; Transcription Factor AP-1 | 2011 |